Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.42 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 3/20 | 0.40 |
| ▸ | CA2 | P00918 | 3/20 | 0.40 |
| ▸ | CA12 | O43570 | 2/20 | 0.40 |
| ▸ | CA7 | P43166 | 2/20 | 0.40 |
| ▸ | CA9 | Q16790 | 2/20 | 0.40 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29598164 | 1.00 | KMT2A (0.50) | KMT2AGABRA1GABRB2TSHRLMNA | |
| SCHEMBL28011839 | 0.98 | KMT2A (0.49) | KMT2AGABRA1GABRB2TSHRLMNA | |
| Hydrochloric Acid SCHEMBL28215358 | 0.95 | KMT2A (0.46) | KMT2AGABRA1GABRB2TSHRLMNA | |
| SCHEMBL12503890 | 0.84 | GABRA1 (0.44) | KMT2AGABRA1GABRB2TSHRLMNA | |
| SCHEMBL10049645 | 0.83 | KMT2A (0.50) | KMT2AALDH1A1CA1CA2CA12 | |
| SCHEMBL17918221 | 0.82 | TSHR (0.47) | KMT2AGABRA1GABRB2TSHRLMNA | |
| SCHEMBL17915487 | 0.80 | KMT2A (0.78) | KMT2ATSHRLMNAALDH1A1 | |
| SCHEMBL12719371 | 0.80 | KMT2A (0.47) | KMT2AALDH1A1POLB | |
| SCHEMBL11299574 | 0.79 | GABRA1 (0.45) | KMT2AGABRA1GABRB2TSHRLMNA | |
| SCHEMBL27901422 | 0.78 | ALDH1A1 (0.57) | KMT2AGABRA1GABRB2TSHRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112574125-A | Method for improving conversion rate of azoxystrobin | 维讯化工（南京）有限公司 | 2021-03-30 | — | — | CN | claimed |
| CN-104230819-B | Method for synthesizing azoxystrobin | 重庆紫光国际化工有限责任公司 | 2017-05-03 | — | — | CN | claimed |
| CN-104230822-B | The synthetic method of Fluoxastrobin | 重庆紫光国际化工有限责任公司 | 2017-03-08 | — | — | CN | claimed |
| CN-104230820-B | The synthetic method of Fluoxastrobin | 重庆紫光国际化工有限责任公司 | 2016-09-28 | — | — | CN | claimed |
| CN-104311493-B | The synthetic method of Fluoxastrobin | 重庆紫光国际化工有限责任公司 | 2016-08-24 | — | — | CN | claimed |
| CN-104230821-B | The synthetic method of Fluoxastrobin | 重庆紫光国际化工有限责任公司 | 2016-07-06 | — | — | CN | claimed |
| EP-2537832-B1 | METHOD FOR PREPARING (E)-METHYL 2-[2-(6-CHLOROPYRIMIDIN-4-YLOXY)PHENYL]-3-METHOXYACRYLATE | CHONGQING UNISPLENDOUR CHEM CO (CN) | 2015-08-12 | — | — | EP | claimed |
| CN-104311493-A | Azoxystrobin synthesis method | CHONGQING UNISPLENDOUR INTERNAT CHEMICAL CO LTD | 2015-01-28 | — | — | CN | claimed |
| CN-104230821-A | Method for synthesizing azoxystrobin | CHONGQING UNISPLENDOUR INTERNAT CHEMICAL CO LTD | 2014-12-24 | — | — | CN | claimed |
| CN-104230820-A | Method for synthesizing azoxystrobin | CHONGQING UNISPLENDOUR INTERNAT CHEMICAL CO LTD | 2014-12-24 | — | — | CN | claimed |
| CN-104230819-A | Method for synthesizing azoxystrobin | CHONGQING UNISPLENDOUR INTERNAT CHEMICAL CO LTD | 2014-12-24 | — | — | CN | claimed |
| CN-104230822-A | Method for synthesizing azoxystrobin | CHONGQING UNISPLENDOUR INTERNAT CHEMICAL CO LTD | 2014-12-24 | — | — | CN | claimed |
| EP-2537832-A1 | METHOD FOR PREPARING (E)-METHYL 2-[2-(6-CHLOROPYRIMIDIN-4-YLOXY)PHENYL]-3-METHOXYACRYLATE | Chongqing Unisplendour Chemical Co., Ltd. (CN) | 2012-12-26 | — | — | EP | claimed |
| CN-101973943-B | Preparation method of (E)-2-[2-(6-pyrimidine-4-yloxy) phenyl]-3-methoxyacrylate | CHONGQING UNISPLENDOUR CHEM CO | 2012-11-21 | — | — | CN | claimed |
| CN-101973943-A | Preparation method of (E)-2-[2-(6-pyrimidine-4-yloxy) phenyl]-3-methoxyacrylate | CHONGQING UNIS CHEMICAL CO LTD | 2011-02-16 | — | — | CN | claimed |
| CN-116239540-A | Preparation method and application of azoxystrobin intermediate | 南通泰禾化工股份有限公司 | 2023-06-09 | — | — | CN | disclosed |
| US-11369113-B2 | Vector control compositions, methods and products utilizing same | SYNGENTA PARTICIPATIONS AG (CH) | 2022-06-28 | — | — | US | disclosed |
| US-20080214587-A1 | Processes For the Preparation of Azoxystrobin Using Dabco as a Catalyst and Novel Intermediates Used in the Processes | SYNGENTA CROP PROTECTION, INC. (US) | 2008-09-04 | — | — | US | disclosed |
| EP-1891020-A2 | PROCESSES FOR THE PREPARATION OF AZOXYSTROBIN USING DABCO AS A CATALYST AND NOVEL INTERMEDIATES USED IN THE PROCESSES | Syngenta Limited (GB) | 2008-02-27 | — | — | EP | disclosed |
| WO-2006114572-A2 | PROCESSES FOR THE PREPARATION OF AZOXYSTROBIN USING DABCO AS A CATALYST AND NOVEL INTERMEDIATES USED IN THE PROCESSES | SYNGENTA LIMITED (GB) | 2006-11-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11369113-B2 | Vector control compositions, methods and products utilizing same | DDT, MSMO1, MGLL | KMT2A 695/4885GABRA1 2453/4885GABRB2 2972/4885 |
| US-20080214587-A1 | Processes For the Preparation of Azoxystrobin Using Dabco as a Catalyst and Novel Intermediates Used in the Processes | DDT, AOC3, DAO | KMT2A 1865/4885GABRA1 2284/4885GABRB2 2038/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.